Yahoo
OTC Markets OTCPK USD

Vimian Group AB (publ) (VIMGF)

2.7700 0.0000 (0.00%)
As of November 2 at 4:00:00 PM EST. Market Open.

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. Alireza Tajbakhsh
Chief Executive Officer 195.47k -- 1983
Mr. Carl-Johan Zetterberg Boudrie
Deputy CEO, CFO & Interim Head of Specialty Pharma 629.12k -- 1978
Ms. Maria Dahllof Tullberg
Head of IR, Communications & Sustainability -- -- 1981
Mr. Carl-Johan Ehn
General Counsel -- -- 1974
Mr. Bart Bremer
Chief People Officer -- -- 1985
Mr. Magnus Kjellberg
Chief Executive Officer of Nextmune -- -- 1973
Mr. Stefano Santarelli
Head of Diagnostics -- -- 1981
Mr. Martin Bengtson
Executive Officer -- -- --
Michael Thunell
Head of Veterinary Services -- -- --
Ms. Lotta Lundaas
Head of MedTech -- -- --

Vimian Group AB (publ)

Riddargatan 19
Stockholm, 11457
Sweden
https://vimian.com
Sector: 
Healthcare
Full Time Employees: 
1,025

Description

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, education, and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and surgical and dental products to veterinary clinics and universities, including dentistry and companion animal orthopedics under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.

Corporate Governance

Vimian Group AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 22, 2026 at 8:00 PM UTC

Vimian Group AB (publ) Earnings Date

Recent Events

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: